Skip to main content
森萱医药 logo

森萱医药 — Investor Relations & Filings

Ticker · 920946 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 417 across all filing types
Latest filing 2022-04-21 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920946

About 森萱医药

https://www.senxuan.cn/

Jiangsu Senxuan Pharmaceutical Co., Ltd. specializes in the research, development, and production of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and specialized fine chemicals. The company’s product portfolio includes key intermediates for antiviral medications, such as those used in the treatment of HIV, and anticonvulsant agents like Primidone. Additionally, it produces high-purity chemical solvents including 1,4-dioxane and 1,3-dioxolane for diverse industrial applications. Senxuan Pharmaceutical maintains a focus on advanced chemical synthesis and large-scale manufacturing capabilities, adhering to international quality standards to support the global life sciences and chemical sectors. Its operations are characterized by a commitment to technical innovation and the supply of critical chemical building blocks for complex therapeutic formulations.

Recent filings

Filing Released Lang Actions
2021年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2021 Annual General Meeting Resolution Announcement" for Jiangsu Senxuan Pharmaceutical Co., Ltd. It details the convening, attendance, and resolutions passed at the 2021 Annual General Meeting held on April 21, 2022. The document includes voting results on various agenda items such as the 2021 annual report, financial statements, profit distribution plan, amendments to company bylaws, and appointment of auditors. It also includes legal opinions confirming the legality of the meeting and voting process. The document is primarily an announcement of the voting results and resolutions passed at the AGM, not the full annual report or financial statements themselves. Therefore, it fits the category of "Declaration of Voting Results & Voting Rights Announcements (DVA)" rather than the full Annual Report (10-K) or AGM Information (AGM-R). The document length (8484 characters) and content support this classification with high confidence.
2022-04-21 Chinese
江苏汇典律师事务所关于江苏森萱医药股份有限公司2021年年度股东大会之法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality of the 2021 Annual General Meeting (AGM) of Jiangsu Senxuan Pharmaceutical Co., Ltd. It details the procedures of convening and holding the AGM, the qualifications of attendees, the voting procedures, and the results of the votes on various agenda items related to the 2021 annual report, financial statements, profit distribution, and other corporate governance matters. The document does not contain the actual annual report or financial statements but rather confirms the legality and validity of the AGM and its resolutions. This type of document is typically classified as AGM Information (AGM-R), as it pertains to materials shared or issued in connection with the AGM, specifically a legal opinion on the AGM proceedings.
2022-04-21 Chinese
2021年年度报告说明会预告公告
Report Publication Announcement Classification · 95% confidence The document is a notice about a scheduled annual report explanation meeting (年度报告说明会预告公告) for the 2021 annual report of 江苏森萱医药股份有限公司. It references the 2021 annual report that was previously disclosed (公告编号：2022-017) and invites investors to participate in a webcast meeting to discuss the report. The document does not contain the annual report itself or detailed financial data, but rather announces the meeting to explain the annual report. The document length is short (991 characters) and it is clearly an announcement of a meeting related to the annual report, not the report itself. Therefore, according to the "Menu vs Meal" rule, this is a Report Publication Announcement (RPA) type filing, as it announces the timing and details of a report explanation meeting rather than providing the report or financial data itself.
2022-04-07 Chinese
授权管理制度
Governance Information Classification · 95% confidence The document is titled '江苏森萱医药股份有限公司授权管理制度' which translates to 'Authorization Management System of Jiangsu Senxuan Pharmaceutical Co., Ltd.' It details the internal authorization management rules, including the delegation of authority from the shareholders' meeting to the board, from the board to the chairman and general manager, and the principles and procedures for decision-making within the company. It is a governance-related document outlining internal rules and management structure rather than financial results, audit opinions, or announcements of voting results. The document is not a report of financial performance or an announcement of a meeting result but a detailed governance policy. Therefore, it fits best under Governance Information (CGR). The document length is 2474 characters, which is sufficient for a substantive governance document rather than a brief announcement or notice.
2022-03-28 Chinese
拟续聘会计师事务所公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the company's intention to renew the appointment of an accounting firm (auditor) for the 2021 fiscal year. It details the auditor's background, independence, audit fees, and the approval process by the board and audit committee. There are no actual financial statements or audit reports included, only information about the auditor appointment and related procedures. The document length is 2781 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as an Audit Report / Information announcement (AR) because it relates to audit matters but is not the full audit report itself. However, given the short length and nature of the content, it is more precisely an announcement about auditor appointment, which fits the Audit Report / Information category rather than a full Annual Report or Audit Report. Confidence is high due to clear references to auditor appointment and audit fees without actual financial data. FY 2021
2022-03-28 Chinese
2021年度财务报表审计报告
Audit Report / Information Classification · 95% confidence The document is titled as an audit report for the fiscal year 2021 of 江苏森萱医药股份有限公司, issued by 天衡会计师事务所, which is an accounting firm. It contains detailed financial statements such as the consolidated balance sheet and consolidated income statement with figures for 2021 and 2020. The presence of detailed financial data, notes, and the auditor's report number indicates this is a standalone audit report rather than a full annual report or an announcement. The document length is substantial (15,000 characters), and it includes actual financial data and audit information. Therefore, it fits the category of Audit Report / Information (AR).
2022-03-28 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.